61 filings
8-K
NTRB
Nutriband Inc
20 May 24
Unregistered Sales of Equity Securities
6:16pm
8-K
NTRB
Nutriband Inc
23 Apr 24
Entry into a Material Definitive Agreement
2:01pm
8-K
NTRB
Nutriband Inc
28 Mar 24
Unregistered Sales of Equity Securities
5:14pm
8-K
NTRB
Nutriband Inc
25 Jan 24
Submission of Matters to a Vote of Security Holders
4:40pm
8-K
NTRB
Nutriband Inc
11 Jan 24
Regulation FD Disclosure
5:07pm
8-K
qak13prsm99
29 Dec 23
Unregistered Sales of Equity Securities
5:25pm
8-K
sjt4ih
14 Jul 23
Entry into a Material Definitive Agreement
9:15am
8-K/A
p5zi5hh0pdlgnst
21 Jun 23
Regulation FD Disclosure
3:50pm
8-K
a136ssm2c
29 Mar 23
Nutriband Secures $2 Million Line of Credit Financing Facility to be Used for Commercialization of AVERSA™ Abuse-Deterrent Transdermal Technology
11:45am
8-K
kvg2joqf
5 Jan 23
Regulation FD Disclosure
11:23am
8-K
ev1wrhwu ic68jq1
30 Dec 22
Unregistered Sales of Equity Securities
4:02pm
8-K
v22lptkq
6 Oct 22
Nutriband Inc. Announces Application for Dual Listing on Upstream
11:46am
8-K
65trd1psqk
19 Aug 22
Unregistered Sales of Equity Securities
4:21pm
8-K
uno1ff3ghx6c3o3cpmry
10 Aug 22
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
ufmsx
1 Aug 22
Nutriband Receives Notice of Allowance from the Canadian Intellectual Property Office for its AVERSA™ Abuse Deterrent Transdermal Technology Patent
8:00am
8-K
137x limskq
27 Jul 22
Regulation FD Disclosure
8:00am
8-K
owaf7
26 Jul 22
Regulation FD Disclosure
8:08am
8-K
r1rd0 qih
15 Jul 22
Regulation FD Disclosure
10:42am
8-K
634ncx787icquzr
31 Jan 22
Regulation FD Disclosure
8:45am
8-K
uxlqa81fbvmbc
27 Jan 22
Nutriband Inc. expands product development pipeline for its AVERSA™ platform abuse deterrent technology
5:03pm